G217-1242 Screening compound: N-[4-({[(4-butoxyphenyl)methyl]carbamoyl}methyl)phenyl]-2,3,4,5-tetrahydro-1H-1-benzazepine-1-carboxamide

G217-1242 Screening compound: N-[4-({[(4-butoxyphenyl)methyl]carbamoyl}methyl)phenyl]-2,3,4,5-tetrahydro-1H-1-benzazepine-1-carboxamide
G217-1242 Screening compound: N-[4-({[(4-butoxyphenyl)methyl]carbamoyl}methyl)phenyl]-2,3,4,5-tetrahydro-1H-1-benzazepine-1-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound G217-1242
N-[4-({[(4-butoxyphenyl)methyl]carbamoyl}methyl)phenyl]-2,3,4,5-tetrahydro-1H-1-benzazepine-1-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

G217-1242

Molecular Formula

C30H35N3O3 (C30 H35 N3 O3)

Compound Name

N-[4-({[(4-butoxyphenyl)methyl]carbamoyl}methyl)phenyl]-2,3,4,5-tetrahydro-1H-1-benzazepine-1-carboxamide

IUPAC name

N-[4-({[(4-butoxyphenyl)methyl]carbamoyl}methyl)phenyl]-2345-tetrahydro-1H-1-benzazepine-1-carboxamide

SMILES

CCCCOc1ccc(CNC(Cc(cc2)ccc2NC(N(CCCC2)c3c2cccc3)=O)=O)cc1

MDL Number (MFCD)

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

485.63

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

12.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

6.180

Distribution Coefficient, logD

6.180

Water Solubility, LogSw

-5.35

Polar Surface Area

56.321

Acid Dissociation Constant (pKa)

13.44

Base Dissociation Constant (pKb)

-0.33

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

33.30

G217-1242 in Drug Discovery

Included in Screening Libraries

3D-Biodiversity Library (27607 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

CNS targets activity set (6557 compounds)

Glucocorticoid receptors Library (4806 compounds)

MCL1 Targeted Library (12200 compounds)

Protein-Protein Interaction Library (218420 compounds)

Regenerative Medicine Focused Library (23016 compounds)

Antibacterial Compounds Library (13827 compounds)

ChemoGenomic Annotated Library for Phenotypic Screening (89798 compounds)

Recognition Elements PPI Library (24135 compounds)

Target Identification, Phenotypic Screening library (TIPS) (27612 compounds)

Included in 1.7M Stock Database

Structure:
  • 3D
  • Mimetics
Therapeutical areas:
  • Cancer
  • Nervous system
  • Hemic and lymphatic
  • Congenital
  • Metabolic
  • Endocrine
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Musculoskeletal
  • Digestive system
  • Hemic and lymphatic
  • Cardiovascular
  • Skin
  • wounds
  • Infections
  • Immune system
  • animal
Targets:
  • Nuclear receptors
Mechanism of action:
  • Receptor's ligands
  • PPI modulators
  • PPI modulators

References: we are preparing a list of scientific research reports with G217-1242 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound G217-1242?
Check Price and Availability of G217-1242, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of G217-1242 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for G217-1242
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for G217-1242
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of G217-1242 available by request